Back to Agenda
Day 1 - Session 2: Accelerated Regulatory Pathway in India
Session Chair(s)
Finny Liu, MSc, RPh
APAC Regional Regulatory Policy Lead
Roche, Singapore
Speaker(s)
Session 2.1: Global trends in the development of the accelerated regulatory pathways for early access
Sundar Ramanan, PhD
Amgen Inc., United States
Director, Global Biosimilars R&D Policy
Session 2.2: OPPI stand on this and how the current process can be further simplified
Suresh Menon
Novartis India Ltd., India
Chief Scientific Officer
Have an account?